Yunfeng M. Fu
Tongzipo Road 138
Changsha, 410013, China
Changsha, 410013, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
tRNA-derived fragment tRF-17-8SPOL52 induces resistance to bortezomib in multiple myeloma via autophagy activation.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: April 19, 2026
Daratumumab-lenalidomide and the immunosuppressive budget in myeloma.
Journal: The Lancet. Oncology
Published: November 29, 2025
Clinical significance of CD45 and CD200 expression in newly diagnosed multiple myeloma patients.
Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
Published: August 11, 2025
MIR4726EccDNA drives bortezomib resistance in multiple myeloma by enhancing MIR4726-5p/NXF1/NKIRAS2 axis dependent autophagy.
Journal: Cell communication and signaling : CCS
Published: March 16, 2025
Identification of RUVBL2 as a novel biomarker to predict the prognosis and drug sensitivity in multiple myeloma based on ferroptosis genes.
Journal: Hematology (Amsterdam, Netherlands)
Published: February 22, 2025
Construction of a prediction model of ultrasound indicators for mortality risk within 7 days in patients with acute myocardial infarction and ventricular septal rupture
Journal: Zhonghua wei zhong bing ji jiu yi xue
Published: December 19, 2024
Acquired Bortezomib Resistance in Multiple Myeloma: From Mechanisms to Strategy.
Journal: Current treatment options in oncology
Published: October 09, 2024
Exosomal tRF-1003 induces angiogenesis via regulating the HIF1α/VEGF signaling in multiple myeloma.
Journal: International immunopharmacology
Published: September 24, 2024
Bone Marrow Mesenchymal Stromal Cells and Their Derived Extracellular Vesicles Protect Pancreatic Beta-TC-6 Cells From Hypoxia-Induced Injury via miR-539-3p-Mediated Downregulation of CD36 Expression.
Journal: Stem cells international
Published: September 23, 2024
AP-1 inhibitor induces ferroptosis via the PI3K/AKT pathway in multiple myeloma cells.
Journal: Heliyon
Published: February 13, 2024
scRNA-Seq and Bulk-Seq Analysis Identifies S100A9 Plasma Cells as a Potentially Effective Immunotherapeutic Agent for Multiple Myeloma.
Journal: Journal of inflammation research
Published: November 27, 2023
Last Updated: 09/26/2026